April 2014
Volume 55, Issue 13
ARVO Annual Meeting Abstract  |   April 2014
Genomic (epigenetic) DNA methylation in patients with open-angle glaucoma
Author Affiliations & Notes
  • Anselm G M Junemann
    Ophthalmology, University of Erlangen Nurnberg, Erlangen, Germany
  • Bernd Lenz
    Department of Psychiatry and Psychotherapy, University of Erlangen Nürnberg, Erlangen, Germany
  • Udo Reulbach
    Department of Child and Adolescent Psychiatry, Our Lady, Dublin, Ireland
  • Ursula Schlotzer-Schrehardt
    Ophthalmology, University of Erlangen Nurnberg, Erlangen, Germany
  • Robert Rejdak
    Department of General Ophthalmology, Medical University of Lublin, Lublin, Poland
    Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland
  • Stefan Bleich
    Clinic of Psychiatry, Socialpsychaitry and Psychotherapy, Hannover Medical School, Hannover, Germany
  • Footnotes
    Commercial Relationships Anselm Junemann, None; Bernd Lenz, None; Udo Reulbach, None; Ursula Schlotzer-Schrehardt, None; Robert Rejdak, None; Stefan Bleich, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 3809. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Anselm G M Junemann, Bernd Lenz, Udo Reulbach, Ursula Schlotzer-Schrehardt, Robert Rejdak, Stefan Bleich; Genomic (epigenetic) DNA methylation in patients with open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2014;55(13):3809.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: DNA methylation occurs by transfer of a methyl group to cytosine residues in the dinucleotide sequence CpG. The extent of DNA methylation positively correlates with the extent of gene inactivation. The disruption of the heritable methylation patterns in DNA can lead to alterations in chromatin structure and alterations in gene expression promoting chronic diseases. The present study was performed to investigate whether there is an altered global DNA methylation in patients with open-angle glaucoma.

Methods: 59 patients from the Erlangen Glaucoma Registry Erlangen Glaucoma Registry, ISSN 2191-5008, CS-2011; NTC00494923) with primary open-angle glaucoma (POAG, age: 68 (SD 8) years), 54 patients with secondary open-angle glaucoma due to pseudoexfoliation syndrome (PEXG, age: 72 (SD 8) years), and 53 patients with cataract as controls (age: 69 (SD 11) years) were included. Total DNA was extracted from frozen EDTA-blood using QIAmp DNA Blood Mini Kit (Qiagen). Global methylation status [DNA methylation in %, 1-(HpaII/MspI)] was measured according to Pogribny et al. (Biochem Biophys Res Commun. 1999; 262:624-8) with a modified non-radioactive assay5. Statistics: Comparisons were made using the Mann-Whitney-Test (2-tailed) and the results are presented as means (SD). A p-value of less than 0.05 was considered significant.

Results: There was a significantly elevated genomic DNA methylation (in %) 1-(HpaII/MspI) in peripheral mononuclear cells in patients with POAG (68%, SD 18; U=868, Z = -2.79, p=0.005), but not in PEXG (55%, SD 17; U=1049, Z=-0.57, p=0.57) when compared with healthy controls (55%, SD 24). Thus, the difference between POAG and PEXG was exactly 13% of methylated HpaII/MspI restriction sites.

Conclusions: Since methylation of DNA is an important epigenetic factor in regulation of gene expression these findings may have important implications for a possible subsequent derangement of epigenetic control in patients with POAG. Further studies including gene-specific analyses are needed to clarify the differences between POAG and PEXG.

Keywords: 539 genetics • 629 optic nerve • 636 pathobiology  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.